Squarepoint’s Medpace MEDP Stock Holding History

Squarepoint’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-700	Closed	-$393K	–	4683
2025 Q4	$393K	Buy	+700	New	+$397K	﹤0.01%	3403

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Squarepoint's MEDP Position: Q2 2026 in Review

Squarepoint reduced its Medpace (MEDP) stake by 69% in Q2 2026, selling an estimated $18.7M and leaving 18,370 shares worth $9.73M. The position accounts for 0.01% of the portfolio, ranked #1124.

Squarepoint first reported a position in MEDP in Q4 2016 and has held it in 31 quarters since. The position peaked at $28.3M in Q1 2026. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Squarepoint held 18,370 shares of Medpace worth $9.73M as of Q2 2026.
Squarepoint sold 40,505 Medpace shares in Q2 2026, an estimated $18.7M.
Medpace made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1124 holding.
Squarepoint first reported a position in Medpace in Q4 2016 and has held it in 31 quarters since.
Squarepoint's Medpace position peaked at $28.3M in Q1 2026.
697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.